Heska (HSKA) Total Current Assets : $238.6 Mil (As of Mar. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Heska Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Heska's total current assets for the quarter that ended in Mar. 2023 was $238.6 Mil.

Heska Total Current Assets Historical Data

The historical data trend for Heska's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heska Total Current Assets Chart

Heska Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Current Assets

Get a 7-Day Free Trial

62.41

139.87

171.28

319.56

265.03

Heska Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Current Assets	Get a 7-Day Free Trial															272.75	272.87	262.81	265.03	238.62

Heska Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Heska's Total Current Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	156.618	+	36.926	+	60.05	+	11.44
	=	265.0

Heska's Total Current Assets for the quarter that ended in Mar. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	125.209	+	36.539	+	64.183	+	12.69
	=	238.6

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Heska (NAS:HSKA) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Heska's Liquidation Value for the quarter that ended in Mar. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	125.209	-	175.044	+	0.75 * 26.054	+	0.5 * 64.183
=	1.8

Heska Total Current Assets Related Terms

Thank you for viewing the detailed overview of Heska's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Heska (HSKA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heska Corp (NAS:HSKA) » Definitions » Total Current Assets

Comparable Companies

AHCO SILK AVNS UFPT FNA PRCT SIBN CTKB OM TMCI ABT MDT SYK BSX EW SZSE:300760 DXCM ZBH ALGN STE

Traded in Other Exchanges

N/A

Address

3760 Rocky Mountain Avenue, Loveland, CO, USA, 80538

Website

https://www.heska.com

Heska Corp is engaged in developing, manufacturing, marketing, selling, and supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments.

Executives

Joachim A. Hasenmaier	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Robert L Antin	director
Mark F Furlong	director	770 M WATER ST, MILWAUKEE WI 53202
Stephen L Davis	director	2901 BUTTERFIELD ROAD, OAK BROOK IL 60523
Providenti Anthony C. Jr.	officer: EVP, Corporate Development	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Kevin S. Wilson	officer: President and COO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Eleanor F. Baker	officer: EVP, Managing Dir. & COO, scil	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Christopher D. Sveen	officer: CAO & General Counsel	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Nancy Wisnewski	officer: EVP, Prod. Dev. & Cust. Supp	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Sharon L. Riley	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Catherine Grassman	officer: EVP, CFO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason D Aroesty	officer: EVP, International Diagnostics	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Bonnie J. Trowbridge	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Scott Humphrey	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason A Napolitano	officer: Exec. VP, CFO & Secretary	1613 PROSPECT PARKWAY, FORT COLLINS CO 80525